Expression of proadrenomedullin derived peptides in the mammalian pituitary: co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes by Montuenga-Badia, L.M. (Luis M.) et al.
Journal of Neuroendocrinology, 2000, Vol. 12, 607–617
Expression of Proadrenomedullin Derived Peptides in the Mammalian
Pituitary: Co-Localization of Follicle Stimulating Hormone and
Proadrenomedullin N-20 Terminal Peptide-Like Peptide in the Same
Secretory Granules of the Gonadotropes
L. M. Montuenga,* M. A. Burrell,* M. Garayoa,* D. Llopiz,* M. Vos,† T. Moody,† D. Garcı´a-Ros,* A. Martı´nez,† A. C. Villaro,*
T. Elsasser‡ and F. Cuttitta†
*Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain.
†Department of Cell and Cancer Biology, DCS, NCI, NIH, Rockville Pike, Bethesda, MD, USA and
‡US Department of Agriculture, Agriculture Research Service, Beltsville, MD, USA.
Key words: adrenomedullin, proadrenomedullin, N-terminal 20 peptide, gonadotropes, pituitary.
Abstract
Expression of proadrenomedullin-derived peptides in the rat, cow and human pituitary was studied
by a variety of techniques. Immunocytochemical detection showed a widespread expression of
adrenomedullin peptide in the adenohypophysis and the neural lobe, with low expression in the
intermediate pituitary. Proadrenomedullin N-20 terminal peptide (PAMP)-immunoreactivity was also
present in the anterior pituitary but showed a more marked heterogeneous distribution, with cells
going from very strong to negative immunostaining. Lower levels of PAMP were found in the neural
lobe. Interestingly, the distribution of adrenomedullin and PAMP immunoreactivity in the anterior
pituitary did not completely overlap. In the present study, we concentrated our efforts to determine
which cell type of the adenohypophysis expresses PAMP. Paraffin and semithin serial sections
immunostained for PAMP and the classical pituitary hormones revealed that a subpopulation of the
gonadotropes expresses high levels of PAMP-immunoreactive material. Ultrastructural analysis
clearly showed PAMP-immunoreactivity in the follicle stimulating hormone (FSH)-containing large
secretory granules of the gonadotropes, suggesting simultaneous secretion of PAMP and FSH by
this cell type. Three mouse adenohypophysis-derived cell lines (AtT20, GH3, and aT3-1 derived from
corticotropes, lacto/somatotropes and gonadotropes, respectively) were also analysed and showed
expression of both proadrenomedullin-derived peptides and their mRNA. Functional studies in these
three cell lines showed that neither adrenomedullin nor PAMP was able to stimulate cAMP
production in our experimental conditions. Taken together, our results support that
proadrenomedullin derived peptides are expressed in the pituitary in cell-specific and not
overlapping patterns, that could be explained by differences in postranslational processing. Our
data showing costorage of PAMP and FSH in the same secretory granules open a way by which
PAMP could be involved in the control of reproductive physiology in a coordinated manner with
FSH.
Adrenomedullin (AM) is a 52 amino-acid amidated peptide several mammals, including human, rat, cow, pig and mouse
(2–6). A second amidated peptide, also a hypotensive molec-that was isolated from pheochromocytoma extracts and was
shown to be a very potent hypotensive molecule in several ule, proadrenomedullin N-20 terminal peptide (PAMP) was
predicted from the amino-acid sequence of its precursormammalian models (1). Most of the reported biological
eVects of adrenomedullin are mediated through the stimula- molecule preproadrenomedullin (7), and has indeed been
detected in plasma of several species, although in lowertion of adenylate cyclases. AM cDNA has been cloned in
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concentrations than its gene-related peptide adrenomedullin adrenomedullin concentrations measured by radio-
immunoassay (RIA) are higher in the pituitary than in any(8, 9).
Although most of the investigative groups working on AM other organ, except for the adrenals. This suggested diVeren-
tial regulation of the expression of PAMP in the pituitaryare concentrated on this peptide’s role in cardiovascular
function, it has now been realized that adrenomedullin may compared to other tissues. In the present study, we show that
there is diVerential regulation in the expression of bothhave much broader pluripotent properties, such as the modu-
lation of bronchodilation (10), aldosterone (11) or insulin peptides in separate cell types within the mammalian
hypophysis.(12) secretion, or glomerular filtration and fractional sodium
reabsorption (13). More recently, the involvement of AM in
the regulation of growth and proliferation has also been
Materials and methodsreported for several cell types in which it has either a
stimulatory (fibroblastic or tumoral cells) or inhibitory Tissues
(mesangial cells) eVect (14). Broad agreement has now been Male and female adult Fisher rats were used to obtain the pituitary. Rats
were killed by inhalation of CO2 and rapidly decapitated. Pituitaries andachieved towards the concept that adrenomedullin is a multi-
adrenal glands were also obtained from normal cows and pigs used for otherfunctional peptide, similar in activity to tumour growth
investigations approved by several USDA experimental protocols. Thesefactor-b. animals were euthanized by captive bolt and exsanguinated. Adrenal gland
There are several reported findings that support the hypo- and pituitary were obtained and immediately placed either into liquid nitrogen
thesis of adrenomedullin playing a potential regulatory role or fixative. Human specimens for histological analysis came from the
Department of Pathology of the University Hospital of Navarra and werein pituitary physiology. A number of investigative approaches
obtained under an approved tissue procurement protocol. Tissues for histo-have already shown expression of adrenomedullin or PAMP
logical analysis were fixed by immersion either in Bouin’s fluid or in 4%
in mammalian pituitary. Radioimmunoassays of protein paraformaldehyde in phosphate buVered saline (PBS) for 24 h and then
extracts of rat, human and pig pituitary have shown the washed in 70% ethanol previously to dehydration and paraYn embedding.
Sections of 3–5 mm in thickness were obtained. We performed a pilot studypresence of moderate to high amounts of immunoreactive
for the optimal time of fixation with Bouin’s solution for our immunocyto-adrenomedullin (15–17). The immunoreactive material from
chemical detection in rat pituitary and we concluded that 12 h gave thehuman pituitary extracts coeluted with synthetic human AM best results.
1–52 in reverse phase high-performance liquid chromato-
graphy (18). Northern blot analyses have also demonstrated Eight rat pituitaries were processed for plastic embedding. Fixation was
achieved by immersion in 0.1% glutaraldehyde plus 4% paraformaldehyde inadrenomedullin expression in several areas of human brain,
phosphate buVer (0.01 M; 0.15 M ClNa; pH 7.4) at 4 °C for 2.5 h. Followingincluding the anterior pituitary (18). Washimine et al. (19)
a 16-h wash at 4 °C, pituitary fragments were dehydrated through ethanolreported the presence of cells immunoreactive for adrenomed-
and propylene oxide and embedded in Epon 812 (23). Semithin sections
ullin in the human and porcine anterior pituitary, but did (1 mm thick) were stained with methylene blue in borate buVer. By inspection
not observe any immunoreactivity in the rat hypophysis. of semithin sections, suitable fields were selected for ultrathin sections which
were stained with uranyl acetate and lead citrate and observed under anTheir report was a review of a variety of organs in several
electron microscope. Immunocytochemical techniques were carried out onspecies, and was not aimed particularly to study the expres-
semithin and ultrathin sections as detailed below.
sion of adrenomedullin and PAMP in the pituitary at the
Cell linescellular level. Several physiological studies have suggested
that exogenously added adrenomedullin can aVect the secre- Three cell lines derived from mouse pituitary adenomas were used in the
present study. GH3 cells are derived from somatotrope/lactotrope adenomation of pituitary hormones either in vitro or in vivo.
and were cultured in RPMI medium supplemented with 10% foetal calf serumAdrenomedullin suppressed basal and corticotropin releasing
(FCS). AtT20 are corticotrope derived cells and were grown in DMEM
factor (CRF )-induced adrenocorticotropic hormone (ACTH) medium supplemented with 10% FCS. aT3-1 cells were derived from a
release from preparations of dispersed rat pituitary cells (20). transgenic mouse in which SV-40 T large antigen is expressed driven by the
human glycoprotein hormone a-subunit promotor giving raise to gona-Although the in vivo studies have not shown yet a clear
dotrope-derived adenomas. This cell line has the biological profiles of anpicture of the regulatory mechanism involved, the reported
immortalized gonadotrope but does not express the mRNA for the follicledata suggest that, in addition to its cardiovascular and fluid stimulating hormone (FSH) or luteinizing hormone (LH) b subunits. aT3-1
regulatory actions, adrenomedullin may be an important cells were grown in DMEM medium supplemented with 10% FCS. GH3 and
hormone involved in the regulation of pituitary/adrenal func- AtT20 cells were a generous gift of Dr Betty Eipper (Department of
Neuroscience, Johns Hopkins University); aT3-1 were donated by Dr Pamellation in mammals (21, 22). Finally, a specific regulation of
Mellon (Department of Reproductive Medicine, University of California atadrenomedullin expression in the pituitary gland was already
San Diego). Cells were harvested from T175 flasks when they were at 80%
suggested by the fact that in the promoter region of the gene confluence and one day after feeding with fresh medium. Total RNA was
coding for mouse adrenomedullin, one Pit-1 binding motif obtained by the guanidine isothiocyanate and caesium chloride protocol. For
immunocytochemical staining, harvested cells were fixed either in Bouin’swas identified, among other several putative regulatory
fluid or in 4% paraformaldehyde in PBS, washed in PBS, and preembeddedsequences (6).
in 2% low melting agarose (FMC Bioproducts, Rockland, ME, USA). TheAlthough there are biochemical and functional data sup- solidified agarose pellets were embedded in paraYn for sectioning.
porting a role for adrenomedullin in pituitary biology, until
Antibodiesnow, very little is known about the actual endocrine cell type
Previously reported well-characterized rabbit anti-AM 22–52 (#2469) or anti-within the hypophysis that produces and probably secretes
PAMP 10–20 (#2463) antisera were used to localize adrenomedullin andadrenomedullin. This lack of information prompted us to
PAMP immunoreactivity in pituitary tissues and cell lines (24, 25). Theinvestigate the distribution of adrenomedullin and PAMP antibody against adrenomedullin was directed to AM 22–52 amide (C-
expression in the mammalian pituitary. We were also particu- terminal ). The antibody against PAMP was directed to PAMPYY 13–20
amide (C-terminal ). Antibodies against rat prolactin (rPRL-IC-5), rat growthlarly intrigued by the fact that the ratios of reported PAMP/
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hormone (rGH-IC-1), rat thyroid stimulating hormone (THS-IC-1), rat FSH staining was observed in the endocrine cells that were more strongly stained
with the antisense probe, probably due to incomplete linearization of the(rFSH-IC-1), rat LH (rLH-IC-1), and human ACTH (hACTH-IC-2) were
generously donated by the National Hormone and Pituitary Program of plasmid combined with leakage of the unused promotor.
NIDDK, NIH, USA.
Western blot
Immunocytochemical technique To extract the proteins, the cell samples were immersed in cold 2X tricine
For the immunocytochemical localization of adrenomedullin and PAMP in sample buVer (with 8% SDS, NOVEX, San Diego, CA, USA) containing
paraYn sections, the avidin-biotin complex (ABC ) technique was employed. 1 mM final concentration of each of the following protease inhibitors:
Optimal dilution for anti-AM 22–52 was 151000, whereas the anti-PAMP pefabloc (Centerchem Inc., Stamford, CT, USA), bestatin and phosphorami-
10–20 was used at 15700. Following overnight treatment with the primary don (Sigma). The cells were then homogenized, sonicated, clarified by
antiserum, sections were incubated with biotinylated goat antirabbit antiserum ultracentrifugation, and the final protein concentration determined (BCA kit,
(Vector Laboratories, Burlingame, CA, USA) diluted 15200. The sections Pierce, Rockford, IL, USA). Protein extracts were diluted to an approximate
were then treated with the avidin-biotin peroxidase complex (Vector protein concentration of 35 mg/50 ml, heated to 95 °C for 3 min and loaded
Laboratories) diluted 15100 in PBS. Peroxidase activity was demonstrated into the sample well. Cell or tissue protein extracts were electrophoretically
using diaminobenzidine/H2O2 as chromogen and substrate, respectively. separated on a gradient 10–20% tricine, SDS-PAGE gel (NOVEX ), and run
Finally, the sections were lightly counterstained with Gills’ haematoxylin. In at 100 V for 2 h under reducing 0,5% b-mercaptoethanol conditions. One ng
some cases, the reaction was intensified with metallic nickel (26). The of synthetic adrenomedullin or 5 ng of PAMP was added to a separate well
intensifying developing reagent was made by mixing a solution of 50 mg of as a positive control. Transfer blotting was accomplished in the same
DAB in 50 ml of deionized H2O with a second solution made up by adding apparatus equipped with a titanium plate electrode and transferred to a
2.5 g of ammonium nickel sulphate (di-Ammonium nickel (II ) sulphate polyvinyldifluoride membrane (Immobilon PVDF, Millipore, Bedford, MA,
6-hydrate; BDH Laboratory Supplies, UK), 200 mg of b-d-glucose (Sigma USA) at 30 V for 3 h. The membrane was blocked overnight in 1% BSA-
Chemical Co., St Louis, MO, USA), 40 mg of ammonium chloride (Sigma) PBS, incubated for 1 h in 151000 dilution of rabbit anti-AM 22–52 (#2469)
and 30 mg of glucose oxidase (Sigma), in 50 ml of acetate buVer (acetic acid or anti-PAMP 10–20 (# 2463), washed three times in PBS, exposed to
0.1 M pH 6). 1×106 cpm 125I-Protein A for 30 min at 4 °C, washed 6 times in PBS, dried
Solid-phase absorption controls were carried out by preincubation (over- and autoradiographed overnight at −80 °C on Kodak XAR5 film. Specificity
night at 4 °C) of the primary antiserum with the equivalent peptide previously control consisted of a duplicate membrane incubated in antigen-preabsorbed
adsorbed to the wall of a polystyrene tube at a concentration of 10 mg/ml. (10 nmol/ml ) antiserum.
Another negative control included the use of nonimmune swine serum as first
Northern blotlayer and gave no immunocytochemical reaction.
Immunocytochemistry at the semithin level was carried out as follows. Equal amounts of total RNA (20 mg) were electrophoresed on 1% agarose
After removing the plastic with a saturated solution of NaOH in methanol gels containing 0.66 M formaldehyde, transferred to ‘Nytran’ filters (Scleicher
(27), semithin sections were rinsed in absolute ethanol, rehydrated in a graded and Schuell, Keene, NH, USA), UV cross-linked and baked for 3 h. Ethidium
series of ethanol, and washed twice in TRIS-HCl buVered saline. The avidin- bromide (33 mg/ml ) was included in the gel to visualize the position of
biotin peroxidase complexes method was identical to that described above, ribosomal RNAs by ultraviolet illumination after electrophoresis.
but microwave pretreatment was used and the incubation time for the primary Hybridization was performed using a 0.55-kb EcoRI fragment of mouse
antisera was increased to 48 h. Microwave pretreatment consisted in a first adrenomedullin (plasmid pcRIIAM ). Blots were hybridized with 32P-labelled
15 min incubation of the sections in a citrate buVer 0.01 M, pH 6.0 at full (3000 Ci/mmol, DuPont, Boston, MA, USA) random-primed probes at 65 °C,
microwave heating power, followed by a second 15 min incubation in the washed and exposed at −70 °C using a DuPont Lightning Plus intensifying
same buVer at half power and a 5-min incubation without heating. Finally, screen (DuPont).
the sections were washed during 10 min in running water. The reaction was
cAMP assayintensified with nickel as described above.
Cyclic AMP was assayed by RIA. Cells in 24-well plates were resuspended
Ultrastructural immunolabelling in SIT medium (3×10−8 M Se2O3; insulin, 5 mg/ml; transferrin, 10 mg/ml )For the ultrastructural studies, the colloidal-gold technique of Merighi et al. containing 1% BSA, 1 mg/ml bacitracin, and 100 mM isobutyl-methyl-
(28) was applied to thin sections mounted on nickel grids. Non-specific xanthine. Adrenomedullin or PAMP was added and after 5 min the reaction
binding sites were blocked with 10% goat immunoglobulins in a buVer [Gold terminated by adding equal volumes of ethanol (0.5 ml ). The cAMP RIA kit
BuVer, GB, Tris-BuVered Saline with 1% bovine serum albumin (BSA) and was purchased from NEN (Boston, MA, USA).
0.05% sodium azide] that was also used for the remaining steps. Thin sections
were incubated overnight at 4 °C with the primary rabbit antiserum (15200)
in GB. Subsequent steps, all at room temperature, included rinses in GB, Results
incubation with the gold-labelled secondary antiserum (goat antirabbit
immunoglobulins conjugated to 20-nm gold particles, Biocell Research
Immunocytochemistry of mammalian pituitaryLaboratories, CardiV, UK) for 1 h, rinses in GB and distilled water, and
double staining with uranyl acetate and lead citrate. The grids were observed
Immunoreactivity for adrenomedullin and PAMP was foundwith a transmission electron microscope.
in human, rat, and cow anterior pituitary (Fig. 1A–D for rat;
In situ hybridization E–F for cow; G–H for human). Immunocytochemical stain-
Detection of the mRNA of adrenomedullin was performed using in situ ing using anti-adrenomedullin antibody showed an extensive
hybridization. A 831-bp adrenomedullin cDNA was obtained from human and generally homogeneous reactivity in a high proportionadrenals mRNA by RT-PCR using the following primers (5∞-TAC CTG GGT
of endocrine cells throughout the rat anterior pituitary,TCG CTC GCC TTC CTA-3∞ and 5∞-CTC CGG GGG TCT CAG CAT
TCA TTT-3∞). The amplified product was ligated in both sense and antisense together with an also homogeneous staining in the neurohy-
orientation into the expression vector pcDNA3, containing SP6 and T7 pophysis adjacent to the anterior lobe (Fig. 1A). The cells of
promoters and used to generate riboprobes. In order to avoid diVerences in the intermediate pituitary were generally not immunostained,
the in vitro translation rate and eYcacy, the same promoter was used for the
with the only exception of some nuclei of endocrine cells thatgeneration of sense and antisense riboprobes. The sense or antisense plasmids
were positive and the flat epithelial cells that separate thewere linearized with NotI and were used as templates to synthesize digoxigenin-
labelled sense or antisense RNA transcripts driven through T7 promoter. anterior from the intermediate pituitary that were strongly
Hybridization was performed in a moist chamber at 46 °C for 20 h in a 20 ml immunoreactive (Fig. 1A). Nuclear staining was sometimes
volume containing the probe. After stringency washes, visualization of also observed in endocrine cells of the anterior lobe (notdigoxigenin was performed using Digoxigenin detection kit (Boehringer
shown). Immunocytochemical results using polyclonal anti-Mannheim, Indianapolis, IN, USA). Sense probes were used as controls and
rendered negative results in most of the cases; in some other cases minor bodies against PAMP showed staining in the anterior but not
© 2000 Blackwell Science Ltd, Journal of Neuroendocrinology, 12, 607–617
610 Adrenomedullin and PAMP in mammalian pituitary
Fig. 1. Serial reverse-face sections of rat adenohypophysis immunostained for adrenomedullin (AM) (A) and proadrenomedullin N-20 terminal
peptide (PAMP) (B). Note the non overlapping staining pattern. Panoramic view of the rat pituitary immunostained with an antibody against PAMP
(C) and the same antibody absorbed with excess peptide (D). Cow anterior pituitary immunostained for PAMP (E, F). Three types of cells concerning
immunostaining are clearly seen, especially at higher magnification (F), with high, intermediate and undetectable staining. Similar pattern of staining
for PAMP is found in human anterior pituitary (G, H). (I–J ) Representative examples of sections of rat pituitary on which in situ hybridization
technique was performed to demonstrate AM mRNA, using an antisense (I ) or a sense (J ) probe. (K ) Showing a detail of a region similar to (I ),
to illustrate heterogeneity of the staining among the adenohypophysis cells. (A, B, E, G, K×360 bar=40 mm; C, D×70 bar=200 mm; F, H×720
bar=20 mm; I, J×150 bar=100 mm.
in the intermediate lobe (Fig. 1B,C). The posterior lobe although in these species the heterogeneity in the intensity of
adrenomedullin was higher as compared to the rat. Westernshowed a homogeneous weak immunoreaction for PAMP,
that was readily absorbed in the controls (Fig. 1B–D). In the blot of human pituitary extracts (Fig. 2) gave adrenomedullin
and PAMP immunoreactive bands, mainly corresponding toanterior lobe, three types of cells could be distinguished
according to the immunostaining pattern for PAMP: some the proadrenomedullin molecule (approximately 22 kDa) and
a processed species (aproximately 17 kDa). In 2 out of 10cells were strongly positive, a second subpopulation showed
a positive immunoreaction of lower intensity and a third cases of human pituitary studied (shown in Fig. 2), a 6-kDa
species, very likely corresponding to completely processedsubpopulation of cells were completely negative for this
antibody (Fig. 1B,C,E–H). In the rat, the cells expressing adrenomedullin could be detected in the western blot using
anti-adrenomedullin antibodies. Similar bands could behigh levels of PAMP-immunoreactive material tended to be
concentrated in the periphery of the anterior lobe, but detected in western blots of cow pituitary (data not shown).
especially near the intermediate pituitary at the tuberal por-
tion (Fig. 1C). Image analysis with relative measurements Expression of adrenomedullin mRNA in the rat pituitary
(area percentage of immunostained cells vs stained plus non
stained cells) showed significant diVerences (P<0.002) In situ hybridization experiments revealed the presence of the
mRNA for adrenomedullin in a variety of endocrine cells ofbetween sexes in the immunocytochemical detection of PAMP
in rat pituitary, the males showing higher immunostained the rat anterior pituitary (Fig. 1I–K). Not all the cells of the
adenohypophysis showed detectable levels of adrenomedullinarea percentage than the females. A similar pattern of distri-
bution of adrenomedullin and PAMP immunostaining was mRNA by this technique, and some degree of heterogeneity
of the intensity of staining suggested diVerences in the levelsobserved when human and cow pituitary were stained,
© 2000 Blackwell Science Ltd, Journal of Neuroendocrinology, 12, 607–617
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Fig. 2. Western blot analysis of proadrenomedullin N-20 terminal peptide (PAMP) and adrenomedullin (AM) in protein extracts of human pituitary.
A total of 10 samples were studied, of which five representative ones are included. The 22 kDa and 17 kDa bands that are detected in most of the
lanes very likely correspond to the preproAM precursor and/or intermediate species in the propeptide processing. Only in samples 3 and 4 a 6-kDa
signal is found, corresponding to processed AM.
of expression among the positive cell types. Intermediate and
neural hypophysis were negative for adrenomedullin mRNA
expression. Sense probes were used as controls and rendered
negative results. The in vitro transcription product from an
empty plasmid was also used as a negative control and gave
completely negative staining.
Expression of adrenomedullin in mouse pituitary cell lines
In order to compare the expression of adrenomedullin and
PAMP in diVerent pituitary cell types, mouse cell lines aT3-1,
AtT-20 and GH3 (derived from mouse gonadotrope-,
corticotrope- and somatotrope/lactotrope-adenomas), were
used. Western blot (Fig. 3A), northern blot (Fig. 3B) and
immunocytochemical (Fig. 4) analysis were carried out.
Western blot analysis for adrenomedullin usually did not
show immunoreactive bands for a 6-kDa species correspond-
ing to bioactive adrenomedullin, but clearly produced other
two more intense bands of higher molecular weight (17 and
22 kDa, respectively) in the three cell lines examined. The
22 kDa band was stronger in the aT3-1 extracts than in those
of the other two cell lines. When antibodies against PAMP
were used in this type of analysis, no band for processed
PAMP was observed in any of the three cell lines, although
in all of them the two bands for the precursor (17 and
22 kDa) were readily detected by this antibody (Fig. 3A).
Northern blot analysis in these cell lines revealed an important
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Fig. 3. (a) Western blot analysis of protein extracts of three mousequantitative diVerence in the expression of the 1.6 kb mRNA
pituitary cell lines using antibodies against adrenomedullin (AM) andspecies among the three cell lines, AtT20 being the one that
proadrenomedullin N-20 terminal peptide (PAMP). (b) Northern blot
expresses highest levels, and GH3 the one that shows less analysis of the total RNA of the same three cell lines using a probe
abundant adrenomedullin messenger mRNA (Fig. 3B). specific for mouse AM mRNA. The lower panel shows ethidium bromide
staining of the gel before transference to show loading.Strong signal by adrenomedullin-like and PAMP-like immu-
noreactive material was observed in the three cell lines. No
obvious diVerence in the immunohistochemical intensity
among the three was found (Fig. 4A–F). was useful to discard GH-, PRL-, and ACTH-producing cells
as the main PAMP-immunoreactive cell type via the compar-
ison of staining patterns. However, the thickness of the
sections precluded cell-to-cell accurate comparison that couldSerial sections and ultrastructural studies
show colocalization of both PAMP and any of the classical
hormones in the same cell. In order to solve this problem,In order to further characterize this heterogeneous population
of cells, and especially to ascertain which cell type corresponds two technical approaches were carried out: serial semithin
sections of plastic embedded material and ultrastructuralto the PAMP strongly immunoreactive cells, we conducted
immunostaining experiments in serial consecutive paraYn studies.
In order to find out which of the classical pituitary cellsections with antibodies directed against PAMP and the
classical pituitary hormones (data not shown). This approach types is expressing higher levels of PAMP in the pituitary,
© 2000 Blackwell Science Ltd, Journal of Neuroendocrinology, 12, 607–617
612 Adrenomedullin and PAMP in mammalian pituitary
Fig. 4. Immunostaining of sections of pellets of the same three cell lines as Fig. 3. (A, B) AtT20; (C, D) GH3; (E, F) aT3-1 using antibodies against
adrenomedullin (AM) (A, C, E) and proadrenomedullin N-20 terminal peptide (PAMP) (B, D, F)×720 bar=20 mm.
we studied semithin and thin sections. Although some degree tural level showed that the PAMP-immunoreactive material
was restricted to the larger FSH-containing granules of theof antigenicity loss is usually caused by the plastic embedding
procedures, we trusted that the high levels of staining gonadotropes (Fig. 6). Unfortunately, our antibodies against
adrenomedullin did not work on semithin plastic-embeddedobserved at the paraYn level would permit visualization of
the PAMP immunoreactive material in semithin sections and sections or at the ultrastructural level with the colloidal-gold
technique in pituitary. Therefore, conclusions about theelectron microscopy, at least in the subpopulation of strongly
immunoreactive cells. Using this approach, we were able to expression and distribution of adrenomedullin have to be
drawn only from the data obtained with the paraYn embed-show a clear colocalization of PAMP with FSH–LH con-
taining gonadotropes (Fig. 5). In semithin sections, both very ded tissues and cell lines.
intense and intermediate PAMP immunoreactive cells were
observed and serial sections showed also that they were not EVect of adrenomedullin and PAMP on cAMP in pituitary cell
immunoreactive for PRL, GH, ACTH or TSH (Fig. 5A–F) lines
but colocalized with FSH and, in some cells, with LH
(Fig. 5G–J). All the PAMP-immunoreactive cells are also Adrenomedullin and PAMP are secreted peptides which may
have either local (autocrine–paracrine) or distant (endocrine)immunostained for FSH and LH. LH cells not immunoreac-
tive for FSH and PAMP were also found with this approach actions. In order to get an idea of the possible target of the
secreted peptide, we have performed experiments of cAMP(Fig. 5G,H), together with LH and FSH immunoreactive
cells that are negative for PAMP (Fig. 5G–J, double arrow). stimulation of the mouse pituitary cell lines with adrenomed-
ullin or PAMP. Both adrenomedullin and PAMP failed toCrossed absorption controls were carried out by incubation
of the anti-PAMP antibodies with either LH or FSH stimulate cyclic AMP production in the three cells lines that
were readily stimulated by either PACAP (Fig. 7) or forskolin(20 nmol/ml ) before the immunostaining procedure. Neither
of the two hormones blocked or reduced the immunostaining (data not shown).
levels for PAMP. A further confirmation of our results came
form the analysis of the localization of PAMP immuno- Discussion
staining at the ultrastructural level (Fig. 6). Colloidal gold
immunocytochemistry was carried out in order to confirm In the present paper, we have shown the expression of
adrenomedullin and its related peptide PAMP in the mamma-the gonadotropic-specific ultrastructural features of the
PAMP-immunoreactive cells. This EM approach was used to lian pituitary. We have also demonstrated a very noticeable
expression of PAMP-immunoreactive material in the gona-ascertain which of the two subpopulation of granules present
in gonadotropes, known to contain either LH or FSH, dotropes which is consistent with previously reported radio-
immunoassay data on PAMP in the pituitary (9). Priorexpressed the stored PAMP-like material. Our results clearly
demonstrated that the only subpopulation of cells in the studies on mammalian tissue extracts have identified a signi-
ficantly higher PAMP/adrenomedullin ratio in the pituitaryanterior pituitary which expressed PAMP immunoreactivity
at the semithin and ultrastructural level were the gona- as compared to other organs in which both peptides have
been found (9). Our report is the first to show PAMPdotropes. Moreover, immunolocalization at the ultrastruc-
© 2000 Blackwell Science Ltd, Journal of Neuroendocrinology, 12, 607–617
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Fig. 5. Three series of semithin serial sections of rat anterior pituitary (A–C, D–F, G–J) immunostained for PAMP (central panels B, E and H ) and
other pituitary hormones, namely prolactin (PRL) (A), growth hormone (GH) (C), adrenocorticotropic hormone (ACTH) (D), thyroid stimulating
hormone (TSH) (F ), luteinizing hormone (LH) (G) and follicle stimulating hormone (FSH ) (J ). Some of the proadrenomedullin N-20 terminal
peptide (PAMP) immunoreactive cells, present in the three sections of each row, are marked by a dotted line. Note that the PAMP immunoreactive
cells are not immunoreactive for PRL, GH, ACTH or TSH but are simultaneously revealed by antibodies against FSH and LH. Some LH/FSH cells
are negative for PAMP (arrows in angled doublet G–H). (A–F) ×1800 bar=10 mm; (G–J)×720 bar=20 mm.
immunoreactivity in pituitary and its localization in FSH/LH conflict with prior observations by Washimine et al. (19). In
their 1995 report, an overview of immunocytochemical ana-cells and the first to demonstrate by western blot that
adrenomedullin precursor is expresed and processed in human lysis of adrenomedullin in a variety of human, rat and pig
organs, including anterior and posterior pituitary, under theirpituitary. All of our western analysis show two bands at
22 kDa and 17 kDa. The 22 kDa product may correspond to experimental conditions, no immunoreactivity was found for
adrenomedullin in the posterior pituitary of any of the threethe preproadrenomedullin peptide (185 amino acids) and the
17 kDa band could correspond to an intermediate product species studied, nor in the anterior pituitary of the rat. In the
anterior lobe of human and porcine pituitary, the authorsof a first cleavage but still a precursor molecule that may
contain the amino acid sequences of both adrenomedullin found adrenomedullin immunoreactive cells with a distribu-
tion diVerent from GH, PRL and ACTH cells. Our resultsand PAMP peptides, as is shown by the immunoreaction
with both antibodies. In any case, none of these precursor do not exclude that cells belonging to these cell types express
adrenomedullin. Although so far we have not been able topeptides have been isolated and sequenced yet. We intend to
do so in the near future. achieve good immunoreactivity for semithin plastic embedded
sections with our anti-adrenomedullin antibody, we aim toOur immunocytochemical results using anti-
adrenomedullin antibodies are in line with our previous try new strategies to find out the correlation between adreno-
medullin-immunoreactivity and the classical pituitaryreports on foetal rat and mouse embryogenesis (24) and with
a recent report on general distribution of adrenomedullin in hormones. The diVerences found between our immunocyto-
chemical results and those of Washimine et al., namely theirrodents using in situ hybridization techniques (29). Among
many other organs, these reports show expression of adreno- lack of immunoreaction in rat pituitary compared to the
abundant expression shown in our data, may be due to themedullin both in the anterior and posterior lobes of the
pituitary. On the contrary, the present data is in partial diVerent characteristics of the antibodies used. In fact, these
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Fig. 6. Serial thin sections of rat pituitary immunostained for proadrenomedullin N-20 terminal peptide (PAMP) (A) and follicle stimulating hormone
(FSH ) (B). The same cell is immunoreactive for both antibodies. Note that the insets are enlargements of the squared areas in (A) and (B). The
colloidal gold particles are clearly seen in the larger granules of the cell. (A, B×13,000, insets×30,000).
authors also report negative staining in organs such as brain, phoretically separable adrenomedullin-and PAMP-immuno-
reactive species in cow pituitary and adrenals, also suggestingkidney or heart, which have now been shown, by other
laboratories using diVerent antibodies, to contain immunore- organ-specific postranslational regulation. An adenohypo-
physis-specific processing of preprocholecystokinin, with mostactive adrenomedullin (13, 30, 31).
The lack of complete overlapping of adrenomedullin and of the propeptide processed to immature non amidated large
peptides, instead of the small amidated products that predom-PAMP immunoreactivity that we have found, may be due to
cell-specific processing of the preproadrenomedullin molecule inate in the principal production sites of gastrin and
cholecystokinin-8, has also been reported (33). Although cell-in each pituitary cell type, in particular the gonadotropes.
All the data available to date on the expression of PAMP in specific post-translational regulation of peptides is a well-
established phenomenon, for example in the proopiomelano-mammals show that the concentration of this peptide in the
plasma or in tissues is always lower than that of adrenomedul- cortin derived peptides (e.g. 34), very little data are available
about this fact in relation to the proadrenomedullin derivedlin. For example, the average human plasma adrenomedullin
concentration in normal adults is around 5.5±0.21 fmol/ml peptides. One of the enzymes required for postranslational
modification of adrenomedullin precursor, peptidyl-glycine(15), whereas PAMP is 0.78±0.12 fmol/ml (8). Consistent
with these data, in our hands immunocytochemical staining a-amidating monooxygenase (PAM), is also widely expressed
in the anterior pituitary and preferentially produced by theusing antibodies against PAMP in other organs always render
much fainter signal compared to the results using antibodies gonadotropes (35).
The gonadotropes are particularly rich in a PAMP-immu-against adrenomedullin (e.g. 24). The pituitary gonadotropes
are a very striking exception to this rule, with a more intense noreactive species and there is a significantly higher expression
of this molecule in the subtype of gonadotropes that accumu-signal for PAMP than for adrenomedullin, suggesting that
an important diVerence exist in the processing of the adreno- late FSH, than in those that are mainly LH secretors.
Heterogeneity within a given cell type in the pituitary cellmedullin precursor protein in this cell type. Cell type-specific
diVerences in the processing of preproadrenomedullin have population is a well established phenomenon that occurs
mainly in the somatotrope/lactotrope and in the gonadotropealso been suggested to explain the significant decrease of the
PAMP/adrenomedullin ratio in protein extracts of pheocrom- cell populations (36). The possible cosecretion of this PAMP-
immunoreactive material and LH/FSH was further supportedocytoma (20%) when compared to normal human adrenals
(39%) (32). Our own unpublished results also show a marked when we performed immunocytochemical techniques at the
ultrastructural level, showing the very precise localization ofvariability in the relative abundance of the diVerent electro-
© 2000 Blackwell Science Ltd, Journal of Neuroendocrinology, 12, 607–617
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for adrenomedullin is more widespread than that of PAMP,
although not so intense. Consistent with this widespread
expression of adrenomedullin in the several cell types that
comprise the pituitary, adrenomedullin mRNA and both
adrenomedullin and PAMP protein were shown to be abund-
ant in the three cell lines studied GH3, AtT20 and aT3-1 that
are derived, respectively, from mouse somatotropes/lacto-
tropes, corticotropes and gonadotropes.
A detailed analysis of the promoter region of the human
and mouse adrenomedullin genes (Genbank accession nos.
D43639 and D78349, respectively) suggests that a number of
putative binding sites for well established pituitary-specific
transcription factors are present, giving further support to
our finding of high expression of this gene in pituitary tissues
and cell lines. Both in human and mouse adrenomedullin
gene promoter, at least one potential gonadotropic-specific
element (GSE), a binding site for steroidogenic factor-1
(SF-1), was found at −779, −754 (reverse) in human and
−729 in mouse (Fig. 8). SF-1 is a member of the steroid
receptor superfamily that has been shown necessary for
gonadotrope diVerentiation within the pituitary. SF-1 is a
transcriptional activator of the human a-subunit, the gonad-
otropin-releasing hormone receptor and the LH-b genes
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Fig. 7. EVect of adrenomedullin (AM) and proadrenomedullin N-20
terminal peptide (PAMP) on cAMP production in mouse pituitary cell
lines. (a) EVect on aT3-1. (b) EVect on GH3. EVect on AtT20 is not
shown but was also non significant for both AM and PAMP.
the PAMP-immunoreactive material to the gonadotrope
secretory granules, especially those of larger size.
Furthermore, the sex-specific diVerences in the expression of
PAMP are parallel to what has already been described for
FSH-containing cells in rat pituitary. A thorough light micro-
scopy and ultrastructural characterization of the heterogen-
eous rat gonadotrope population has recently been published
(37) showing two main types of morphologically and immu-
noreactivelly distinct granules: a small round electrondense
granule with an average diameter of 200 nm and a larger less
opaque granule of 400–700 nm, the former type being only
immunoreactive to LH antibodies and the later accumulating
both LH and FSH. PAMP immunoreactivity was mainly
localized to the larger FSH containing granules, suggesting a
possible simultaneous release of PAMP and FSH upon stimu-
lation, and also supporting a possible involvement of PAMP
or adrenomedullin in the regulation of reproductive functions.
Changes in the expression of adrenomedullin in the female
reproductive organs, in parallel with the reproductive cycle
have already been reported (38). The high concentration of
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PAMP in gonadotropes does not exclude these and the other Fig. 8. Potential binding sites for pituitary-specific transcription factors
in the mouse and human preproadrenomedullin gene.cell types making adrenomedullin. In fact, immunostaining
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(39–41) in the gonadotropes and is highly expressed in this and maybe an involvement of adrenomedullin-related pep-
tides in the hormonal control of reproductive functions.cell type (42) but not in the other pituitary endocrine cells.
These findings and the localization of a proadrenomedullin- In summary, our collective data demonstrate the expression
of proadrenomedullin derived peptides in the endocrine cellsderived peptide found in our study in the gonadotropes
suggest that SF-1 may be implicated in the regulation of of the pituitary in a variety of mammalian species. In addition,
these peptides have been found in adenohypophysis-derivedadrenomedullin-gene expression through the GSE present in
its promoter. Putative consensus sequences for other adenohy- cell lines. We have also localized PAMP-like immunoreactive
material to the FSH-containing granules of the gonadotropes.pophysis-specific transcription factors have also been found
in the 5∞ adrenomedullin promoter region of both human and Our morphological and functional data suggest a possible
involvement of the proadrenomedullin derived peptides inmouse genes [for a review on pituitary transcription factors,
see (43)]. Pit-1, a helix-turn-helix homeobox protein has been the central endocrine control of reproduction.
the object of numerous studies and has been shown to
regulate the expression of the GH, PRL, TSHa and growth
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